Elaboration of a Pronostic Score of Changes on Wheelchair's Seating System
ConditionNeuromuscular Diseases
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssistance Publique - Hôpitaux de Paris
About this trial
Development and validation study of a prognostic score - study of prognostic performance by a prospective longitudinal multicenter cohort spread over 8 centers: 4 for the development cohort and 4 for the validation cohort).
Eligibility criteria
Qualifiers
Male or female over the age of 18
Daily wheelchair user (more than 4 hours per day)
Having a neuromuscular disease such as Duchenne Muscular Dystrophy or Infantile Spinal Muscular Atrophy type II
Accompanied by an identified medical equipment provider, able to respond to the recommendations of the clinical team
Disqualifiers
Person who already has a seat change or FR prescription at the time of inclusion
Having undergone surgery less than 1 year ago or a fracture
Pregnant or breastfeeding women
Patient under guardianship or curatorship.
Trial design
Treatments tested in this trial
- usual care
Treatment groups
368 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov